Search Results - "Human epidermal growth factor receptor 2"

Molecular genetic markers of breast cancer: current advances in understanding the etiology, prognostic value, and therapeutic opportunities

Authors: M. M. Omarov V. V. Trusova L. M. Agabekyan et al.

Source: Акушерство, гинекология и репродукция, Vol 0, Iss 0 (2020)

Subject Terms: breast cancer gene, her2, human epidermal growth factor receptor 2, cell proliferation marker ki-67, Gynecology and obstetrics, til, molecular markers of tumor cells, bc, breast cancer, pd-l1, programmed cell death receptor ligand 1, tumor-infiltrating lymphocytes, brca, RG1-991

Access URL: https://doaj.org/article/a8c2cf51c416451db59fca6db1464eb9

Clinical application of trastuzumab and docetaxel in the chemotherapy of human epidermal growth factor receptor 2 positive breast cancer patients

Authors: Qian, Jian Xu, Yunxia Ling, Xiaokai et al.

Source: African Journal of Reproductive Health; Vol. 29 No. 5 (2025): Special Edition; 97-104

Subject Terms: Adult, Receptor, ErbB-2, Human epidermal growth factor receptor 2, breast cancer, docetaxel, trastuzumab, chemotherapy, quality of life, Breast Neoplasms, Antineoplastic Agents, Docetaxel, Trastuzumab, Middle Aged, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Humans, Female, Récepteur 2 du facteur de croissance épidermique humain, cancer du sein, docétaxel, trastuzumab, chimiothérapie, qualité de vie

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40391840
https://www.ajol.info/index.php/ajrh/article/view/298852

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer

Authors: Jampana Sahitya Kavya Kilaparti Meghala Batchu

Source: Current Medicine Research and Practice, Vol 15, Iss 3, Pp 88-94 (2025)

Subject Terms: human epidermal growth factor receptor 2, triple-negative breast cancer, Medicine, non-triple-negative breast cancer, progesterone receptor, oestrogen receptor

Access URL: https://doaj.org/article/4957f08e03674e54a7aeea1c87ad5e80

Comparison of the efficacy of different dual-targeted combined chemotherapy regimens for treating HER2-positive breast cancer

Authors: Yu-hua Xia Jin Yuan Yi-ling Huang

Source: Asian Journal of Surgery, Vol 48, Iss 8, Pp 5235-5237 (2025)

Subject Terms: Human epidermal growth factor receptor 2, Breast cancer, Pertuzumab, Efficacy, RD1-811, Surgery, Trastuzumab

Access URL: https://doaj.org/article/3138fe18ffd54f7b993f29ab240270b4

Preoperative prediction of the HER2 status and prognosis of patients with endometrial cancer using multiparametric MRI-based radiomics: a multicenter study

Authors: Guihan Lin Weiyue Chen Yongjun Chen et al.

Source: Scientific Reports, Vol 15, Iss 1, Pp 1-11 (2025)

Subject Terms: Human epidermal growth factor receptor 2, Endometrial cancer, Magnetic resonance imaging, Radiomics, Prognosis, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/029fc72840a04dc2a0c872a05b044525

Multimodal imaging and advanced quantitative techniques for HER-2 status prediction in breast cancer

Authors: Qingxue Wang Ning Zheng Qingqing Yu et al.

Source: Discover Oncology, Vol 16, Iss 1, Pp 1-19 (2025)

Subject Terms: Breast cancer, Human epidermal growth factor receptor 2, MRI, Radiomics, Deep learning, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2730-6011

Access URL: https://doaj.org/article/57bcaf3e78bd47f494d1cbbc3c55d91d

Epidemiology and outcomes associated with brain metastases among patients with metastatic breast cancer – a cohort study in US electronic health record data

Authors: Della Varghese Jenna Collins Beth Nordstrom et al.

Source: BMC Cancer, Vol 25, Iss 1, Pp 1-15 (2025)

Subject Terms: Metastatic breast cancer, Brain metastases, Human epidermal growth factor receptor 2, HER2-positive, HER2-negative, Systemic therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/694d0122e956471da0452c171f6b74da

Highly Sensitive Detection and Molecular Subtyping of Breast Cancer Cells Using Machine Learning-assisted SERS Technology

Authors: Xinyu Miao Lei Xu Li Sun et al.

Source: Nano Biomedicine and Engineering, Vol 17, Iss 1, Pp 129-142 (2025)

Subject Terms: breast cancer, machine learning, human epidermal growth factor receptor 2 (her-2), QH301-705.5, surface-enhanced raman spectroscopy (sers), Medicine, gold nanoparticles (au nps), Biology (General), bioprobes

Access URL: https://doaj.org/article/503d85d56b3d41a28ccc1a01ac6f7265

Light on the horizon for HER2 overexpressing non-small cell lung cancer?

Authors: Koster, Kira-Lee Früh, Martin

Source: Transl Lung Cancer Res

Subject Terms: trastuzumab deruxtecan, Editorial Commentary, human epidermal growth factor receptor 2 (HER2), Non-small cell lung cancer (NSCLC)

Access URL: https://pubmed.ncbi.nlm.nih.gov/40114964

Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial)

Authors: Li R Wang M Kong X et al.

Source: Drug Design, Development and Therapy, Vol 19, Iss Issue 1, Pp 8463-8474 (2025)

Subject Terms: Breast cancer, Human epidermal growth factor receptor 2, Trastuzumab-resistant, Pyrotinib, Eribulin, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.dovepress.com/eribulin-plus-pyrotinib-in-trastuzumab-resistant-her2-positive-advance-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881

Access URL: https://doaj.org/article/5438a3776c034b4fb255bc1a46b62384

Advances in Targeted Therapy for Advanced Non-small Cell Lung Cancer with HER2 Mutation

Authors: Jinyu YU Baoshan CAO

Source: Chinese Journal of Lung Cancer, Vol 28, Iss 8, Pp 612-620 (2025)

Subject Terms: lung neoplasms, human epidermal growth factor receptor 2, mutation, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1009-3419; https://doaj.org/toc/1999-6187

Access URL: https://doaj.org/article/eae7f1054fb24d78a7fd7b3856e78fc6

AI microscope facilitates accurate interpretation of HER2 immunohistochemical scores 0 and 1+ in invasive breast cancer

Authors: Zong La Jie Chen Xunxi Lu et al.

Source: Scientific Reports, Vol 15, Iss 1, Pp 1-9 (2025)

Subject Terms: Breast cancer, Human epidermal growth factor receptor 2, Immunohistochemistry, Artificial intelligence, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/db5eb4ec83184becbb29f3f09bd96eff

Evaluation of HDL-C and Gene Expression of HER2 in Male and Female Breast Cancer and Risk Individual for Breast Cancer Development

Authors: Elaph Ali AL-Esawi Buthainah Abbas Al-Azzawi

Source: Medical Journal of Babylon, Vol 22, Iss 3, Pp 681-685 (2025)

Subject Terms: chromosome 17, dyslipidemia, human epidermal growth factor receptor 2 (her2), male breast cancer, scavenger receptor type 1 class b (sr-bi), Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1812-156X; https://doaj.org/toc/2312-6760

Access URL: https://doaj.org/article/715788d019204acb8eebc12413384202

Interobserver Variability in HER2 Breast Biomarker Reporting: Implications for Diagnostic Consistency and Treatment Precision

Authors: Hira Batool, Sameen Afzal, Fatima Khalid, Saira Javeed, Zonaira Rathore, Akhter Sohail Chughtai

Source: Journal of Islamic International Medical College, Vol 20, Iss 2, Pp 80-85 (2025)

Subject Terms: asco guidelines, equivocal cases, human epidermal growth factor receptor 2, interobserver variability, invasive breast cancer., Medicine

File Description: electronic resource

Relation: https://journals.riphah.edu.pk/index.php/jiimc/article/view/2303; https://doaj.org/toc/1815-4018; https://doaj.org/toc/2410-5422

Access URL: https://doaj.org/article/04e2583bcab448e1bfeda9931928063b

Affibody-based targeting agent 131I-YZHER2: V2 for HER2-positive ovarian cancer xenografts

Authors: Hongyu Hu Xianwen Hu Fangming Li et al.

Source: Front Med (Lausanne)
Frontiers in Medicine, Vol 12 (2025)

Subject Terms: radionuclide targeted therapy, affibody, Medicine (General), R5-920, HER2, human epidermal growth factor receptor 2, 131 I, Medicine

Access URL: https://doaj.org/article/2241165a6ba14f3badc2c651e6d98825

New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer

Authors: Britten, Karissa McAndrew, Nicholas

Source: Current Opinion in Obstetrics & Gynecology. 36(1)

Subject Terms: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Women's Health, Breast Cancer, Cancer, Humans, Female, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Receptor, ErbB-2, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, human epidermal growth factor receptor 2 testing, human epidermal growth factor receptor 2+breast cancer, human epidermal growth factor receptor 2-low breast cancer, human epidermal growth factor receptor 2-targeted therapy, Receptor, erbB-2, Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine, Reproductive medicine

Access URL: https://escholarship.org/uc/item/9qd363kb

Expression of Her-2 and Ki-67 in Gastric Cancer Formalin Fixed Paraffin Embedded Tissue Blocks and Their Correlation with Histological Grades at the Uganda Cancer Institute Pathology Laboratory

Authors: Hassan Wasswa Abraham Birungi Lawrence Amadile et al.

Source: Pathology and Laboratory Medicine International, Vol Volume 16, Pp 23-33 (2024)

Subject Terms: immunohistochemistry, human epidermal growth factor receptor 2, Pathology, RB1-214, nuclear proliferation-associated antigen, histology grade

Access URL: https://doaj.org/article/412dd0b705cd4e36b93e4d48f09f9c90

Screening, docking, and molecular dynamics analysis of Mitragyna speciosa (Korth.) compounds for targeting HER2 in breast cancer

Authors: Nabila Hadiah Akbar Farendina Suarantika Taufik Muhammad Fakih et al.

Source: Current Research in Structural Biology, Vol 10, Iss , Pp 100171- (2025)

Subject Terms: Breast cancer (BC), Human epidermal growth factor receptor 2 (HER2), Mitragyna speciosa (Korth.), Natural compounds screening, Molecular interactions approach, Biology (General), QH301-705.5

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2665928X2500008X; https://doaj.org/toc/2665-928X

Access URL: https://doaj.org/article/d5c857814a984e11b28a4d902c922b13

TCTN1 promotes epithelial⁃mesenchymal transition to mediate trastuzumab resistance in HER2⁃positive breast cancer

Authors: CHEN Luhong*，GAO Hao，JI Jie，ZHU Xiaochao

Source: Zhongguo linchuang yanjiu, Vol 38, Iss 11, Pp 1715 -1719 (2025)

Subject Terms: breast cancer, human epidermal growth factor receptor 2, tectonic family member 1, epithelial⁃mesenchymal transition, trastuzumab, drug resistance, Medicine

File Description: electronic resource

Relation: http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20251118; https://doaj.org/toc/1674-8182

Access URL: https://doaj.org/article/2fcbeb22150f44689021276d9b169aca

Information needs and barriers to patient-centered care in oncology: EtnobreastHER2, an ethnographic study with HER2+ MBC patients and their healthcare providers

Authors: José Ángel García-Sáenz Álvaro Rodríguez-Lescure Silvia Antolin et al.

Source: Frontiers in Medicine, Vol 12 (2025)

Subject Terms: human epidermal growth factor receptor 2 metastatic breast cancer, oncology, patient-centered care, informational needs, doctor-patient communication, structural barriers, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2025.1592380/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/c27df01ca2dd4c759ac101ed147ca891